Inquire Before Buying - UAE Left Ventricular Assist Devices (LVADs) Market Size By 2030

UAE Left Ventricular Assist Devices (LVADs) Market Research Report Forecast: (2025-2030)

UAE Left Ventricular Assist Devices (LVADs) Market - By Type of Flow (Pulsatile Flow, Non-Pulsatile Flow), By Design (Implantable Ventricular Assist Devices, Transcutaneous Ventric......ular Assist Devices), By Application (Bridge to Transplantation, Destination Therapy, Bridge to Recovery, Bridge to Candidacy) and Others Read more

Healthcare
Jan 2025
Pages 121
Report Format: PDF, Excel, PPT

Market Definition

A surgically implanted pump is a left ventricular assist device or LVAD, aiding the pumping of blood from the left lower chamber in the heart. Pumping oxygen-rich blood into the aorta and eventually to all the other organs is done by the left ventricle assisted through the device in case of heart disease.

Market Insights & Analysis: UAE Left Ventricular Assist Devices (LVADs) Market (2025-30):

The UAE Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 391.29 million in 2024 and is projected to reach USD 511.22 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.45% during the forecast period, i.e., 2025-30. Numerous significant factors are driving the market for left ventricular assist devices in the United Arab Emirates. The various healthcare initiatives started by the UAE government with the goal of improving cardiovascular care and creating an environment that is favorable for the use of LVAD are a major source of motivation.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD 391.29 Million
Market Value in 2030	USD 511.22 Million
CAGR (2025-30)	4.45%
Top Key Players	Abbott Laboratories, Cadrenal Therapeutics, Fresenius Medical Care AG & Co. KgaA, Abiomed Inc., Teleflex Incorporated, SynCardia Systems, CardiacAssist, Inc., Jarvik 2000, Reliant Heart, Edwards Lifesciences, GE Healthcare, and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

To fight against cardiovascular diseases, the UAE's Ministry of Health and Prevention started an initiative to identify research priorities. Additionally, advancements in LVAD technology have increased their use by making them simpler to implant, more compact, and more efficient. Moreover, growing public and healthcare professional knowledge of heart disease and LVAD technology has improved market acceptability especially as heart disease awareness campaigns proliferate. Moreover, as heart failure cases rise, LVADs are becoming critical in stabilizing patients awaiting heart transplants. With a strong focus on improving healthcare access and quality, the private healthcare sector is increasingly adopting LVADs, expanding market access.

Furthermore, the pediatric LVAD market in the UAE is an untapped opportunity, with few solutions available for younger patients suffering from severe heart failure. As research and development efforts intensify, innovations in LVAD technology are expected to improve patient outcomes and drive market growth. Telemedicine and remote monitoring for LVAD patients is another promising opportunity to improve post-implant care and reduce hospital readmissions. Moreover, the trend toward less invasive LVAD techniques is significant because they are less risky and require less recovery time. This trend will continue as continuous-flow LVADs become more popular because of their effectiveness compactness and reduced complications. To guarantee better care of patients on LVAD, hospitals in the United Arab Emirates are also using cutting-edge technologies like remote monitoring more frequently. The growing call for LVADs, in which patient-centric care for transplantation could improve survival rate, also forced LVAD to be customized to meet the needs of the patients. Thus, all these reasons add up to the UAE LVAD being one of the fastest-growing markets in the region offering new solutions and better access to healthcare services for an increasingly busy population.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
UAE Left Ventricular Assist Devices (LVADs) Market Trends & Developments
UAE Left Ventricular Assist Devices (LVADs) Market Start-up Ecosystem
1. Entrepreneurial Activity
2. Funding Received by Top Companies
3. Key Investors Active in the Market
4. Series-wise Funding Received
  1. Seed Funding
  2. Angel Investing
  3. Venture Capitalists (VC) Funding
  4. Others
UAE Left Ventricular Assist Devices (LVADs) Market Industry Dynamics
1. Growth Drivers
2. Challenges
UAE Left Ventricular Assist Devices (LVADs) Market Opportunities & Hotspots
UAE Left Ventricular Assist Devices (LVADs) Market Value Chain Analysis
UAE Left Ventricular Assist Devices (LVADs) Market Regulations and Policy
UAE Left Ventricular Assist Devices (LVADs) Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Flow
    1. Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
    2. Non-Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
  2. By Design
    1. Implantable Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
    2. Transcutaneous Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
  3. By Application
    1. Bridge to Transplantation - Market Size & Forecast 2020-2030, USD Million
    2. Destination Therapy - Market Size & Forecast 2020-2030, USD Million
    3. Bridge to Recovery - Market Size & Forecast 2020-2030, USD Million
    4. Bridge to Candidacy - Market Size & Forecast 2020-2030, USD Million
  4. By Region
    1. Dubai
    2. Abu Dhabi
    3. Sharjah
    4. Northern Emirates
  5. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
UAE Pulsatile Flow Left Ventricular Assist Devices (LVADs) Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Design - Market Size & Forecast 2020-2030, USD Million
  2. By Application - Market Size & Forecast 2020-2030, USD Million
  3. By Region-Market Size & Forecast 2020-2030, USD Million
UAE Non-Pulsatile Flow Left Ventricular Assist Devices (LVADs) Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Design - Market Size & Forecast 2020-2030, USD Million
  2. By Application - Market Size & Forecast 2020-2030, USD Million
  3. By Region-Market Size & Forecast 2020-2030, USD Million
UAE Left Ventricular Assist Devices (LVADs) Market Strategic Imperatives for Growth & Success
Competition Outlook
1. Abbott Laboratories
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
2. Cadrenal Therapeutics
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
3. Fresenius Medical Care AG & Co. KGaA
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
4. Abiomed Inc.
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
5. Teleflex Incorporated
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
6. SynCardia Systems
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
7. CardiacAssist, Inc.
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
8. Jarvik 2000
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
9. Reliant Heart
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
10. Edwards Lifesciences
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
11. GE Healthcare
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
12. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *